Therapeutic bonds linked to CCR9

VN10059526BActive Publication Date: 2026-08-03MEDIMMUNE LTD

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: VN1202305954
Authority / Receiving Office: VN · VN
Patent Type: Patents
Current Assignee / Owner
Filing Date: 2022-03-17
Publication Date: 2026-08-03
Estimated Expiration: 2042-03-17

Application Information

Patent Timeline

17 Mar 2022

Application

VN1202305954

03 Aug 2026

Publication

VN10059526B

Inventors: NYS, Josquin Arnaud; THOM, Albert George

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The invention relates to a binding molecule, such as an antibody, that binds to the chemokine receptor CCR9. Specifically for asthma, the invention relates to the treatment of a disease or condition mediated by CCR9, such as inflammatory bowel disease (IBD), and methods for detecting CCR9, using the binding molecule as invented.

Need to check novelty before this filing date? Find Prior Art